Profound Medical Corp (PRN.TO)
10.01
-0.07
(-0.69%)
CAD |
TSX |
May 31, 16:00
Profound Medical Enterprise Value: 197.56M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 197.56M |
| May 30, 2024 | 199.27M |
| May 29, 2024 | 199.51M |
| May 28, 2024 | 197.31M |
| May 27, 2024 | 191.45M |
| May 24, 2024 | 199.27M |
| May 23, 2024 | 200.98M |
| May 22, 2024 | 218.81M |
| May 21, 2024 | 217.10M |
| May 17, 2024 | 226.38M |
| May 16, 2024 | 234.20M |
| May 15, 2024 | 234.44M |
| May 14, 2024 | 231.27M |
| May 13, 2024 | 208.30M |
| May 10, 2024 | 210.99M |
| May 09, 2024 | 237.37M |
| May 08, 2024 | 204.88M |
| May 07, 2024 | 202.69M |
| May 06, 2024 | 198.29M |
| May 03, 2024 | 198.78M |
| May 02, 2024 | 197.56M |
| May 01, 2024 | 198.53M |
| April 30, 2024 | 207.08M |
| April 29, 2024 | 209.53M |
| April 26, 2024 | 217.83M |
| Date | Value |
|---|---|
| April 25, 2024 | 228.09M |
| April 24, 2024 | 216.85M |
| April 23, 2024 | 211.48M |
| April 22, 2024 | 211.24M |
| April 19, 2024 | 203.42M |
| April 18, 2024 | 210.50M |
| April 17, 2024 | 214.17M |
| April 16, 2024 | 216.12M |
| April 15, 2024 | 217.83M |
| April 12, 2024 | 221.25M |
| April 11, 2024 | 225.16M |
| April 10, 2024 | 220.52M |
| April 09, 2024 | 225.40M |
| April 08, 2024 | 226.63M |
| April 05, 2024 | 221.50M |
| April 04, 2024 | 226.38M |
| April 03, 2024 | 233.47M |
| April 02, 2024 | 230.78M |
| April 01, 2024 | 227.85M |
| March 31, 2024 | 232.00M |
| March 28, 2024 | 253.64M |
| March 27, 2024 | 248.02M |
| March 26, 2024 | 246.06M |
| March 25, 2024 | 247.04M |
| March 22, 2024 | 249.24M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
27.21M
Minimum
Oct 26 2022
613.05M
Maximum
Feb 05 2021
238.23M
Average
232.28M
Median
Enterprise Value Benchmarks
| Biocure Technology Inc | 1.450M |
| Core One Labs Inc | 8.573M |
| Nova Mentis Life Science Corp | 2.919M |
| Nanosphere Health Sciences Inc | 0.2959M |
| Lobe Sciences Ltd | 3.658M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.357M |
| Revenue (Quarterly) | 2.575M |
| Total Expenses (Quarterly) | 12.66M |
| EPS Diluted (Quarterly) | -0.3505 |
| Gross Profit Margin (Quarterly) | 66.44% |
| Profit Margin (Quarterly) | -324.6% |
| Earnings Yield | -17.40% |
| Normalized Earnings Yield | -16.95 |